EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program

Hailei Du iD, Tong Lang iD, Xiaoxue Zha iD, Chao Qu iD, Ling Chen iD, Shihua Yao iD, Xing Feng iD, Zhaohui Jin iD

Proceedings of the National Academy of Sciences · 17.11.2026 · 123 (46)

DOI: 10.1073/pnas.2632549123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.10.2026. Verfasst von Hailei Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
  • Department of Respiratory and Critical Care Medicine, Weifang Second People's Hospital, Weifang, Shandong 261041, China.
  • Department of Intensive Care Medicine, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui…
  • Department of Intensive Care Medicine, Anhui Provincial Cancer Hospital, Hefei, Anhui 230031, China.
  • Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin 130012, China.
  • Department of Public Laboratory Platform, The First Hospital of Jilin University, Changchun, Jilin 130012, China.

ORCID-Profile: Hailei Du, Tong Lang, Xiaoxue Zha, Chao Qu, Ling Chen, Shihua Yao, Xing Feng, Zhaohui Jin

Zitieren

APA

Du, H., Lang, T., Zha, X., Qu, C., Chen, L., Yao, S., Feng, X., & Jin, Z. (2026). Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program. Proceedings of the National Academy of Sciences, 123(46). https://doi.org/10.1073/pnas.2632549123

Vancouver

Du H, Lang T, Zha X, Qu C, Chen L, Yao S, et al. Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program. Proceedings of the National Academy of Sciences. 2026;123(46). doi:10.1073/pnas.2632549123

BibTeX
@article{Du2026,
  author = {Du, Hailei and Lang, Tong and Zha, Xiaoxue and Qu, Chao and Chen, Ling and Yao, Shihua and Feng, Xing and Jin, Zhaohui},
  title = {Reply to Yu and Yu: Clarifying the role of carnitine metabolism in the ALDH9A1-associated immunotherapy resistance program},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {46},
  doi = {10.1073/pnas.2632549123}
}
Kostenlos starten →